logo
light
search

MedWellAI Revenue Surges 647% to $1.08M in H1 FY2026 as Losses Narrow

MedWellAI, Inc., a healthcare AI technology company, reported revenue of $1.08 million for the six months ending December 31, 2025, up from $144,009 in the year-ago period. The company posted a net loss of $939,397, narrowing from a loss of $1.89 million a year earlier.

MedWellAI, Inc., a healthcare AI technology company, reported revenue of $1.08 million for the six months ending December 31, 2025, up from $144,009 in the year-ago period. The company posted a net loss of $939,397, narrowing from a loss of $1.89 million a year earlier. Read more earnings reports.

Revenue for the three months ending December 31, 2025 came in at $548,315, a 284% increase from $142,861 in the same quarter of the prior year. The quarterly net loss was $287,519, less than half the $673,911 loss reported in the year-ago quarter.

The operating loss for the six-month period narrowed to $600,022 from $904,080 a year earlier. For the quarter, the operating loss was $273,988, down from $315,096 in the prior-year quarter.

Balance Sheet Deteriorates

Total assets fell to $460,888 as of December 31, 2025, down from $805,500 six months prior. Cash and restricted cash declined to $137,503 from $401,310 during the same period.

Total liabilities more than doubled to $7.75 million from $3.14 million at the end of June 2025. Current liabilities jumped to $7.68 million from $3.06 million. Stockholders' equity deficit widened to negative $7.45 million from negative $6.62 million.

Cash Flow Pressures Continue

The company burned $255,749 in cash from operations during the six months ending December 31, 2025, compared to $461,576 in the year-ago period. Cash used in investing activities was $8,058, a sharp reversal from the $638,280 generated from investing in the prior-year period.

The company reported no financing activity during either the current or prior-year six-month periods.

Equity Structure

Common shares outstanding increased to 6,236,580 as of December 31, 2025, from 6,186,580 six months earlier. The retained earnings deficit widened to $89.61 million from $88.67 million at the end of June 2025.

ItemQ2 FY2026Q2 FY2025H1 FY2026H1 FY2025
Revenue$548,315$142,861$1,075,806$144,009
Operating Loss($273,988)($315,096)($600,022)($904,080)
Net Loss($287,519)($673,911)($939,397)($1,889,958)
Cash from Operations($255,749)($461,576)
Balance Sheet ItemDec 31, 2025Jun 30, 2025
Total Assets$460,888$805,500
Cash & Restricted Cash$137,503$401,310
Total Liabilities$7,752,412$3,140,935
Stockholders' Equity($7,453,861)($6,624,599)